ID   APOA5_RAT               Reviewed;         367 AA.
AC   Q9QUH3; Q5FVT8;
DT   01-FEB-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   02-OCT-2024, entry version 134.
DE   RecName: Full=Apolipoprotein A-V;
DE            Short=Apo-AV;
DE            Short=ApoA-V;
DE   AltName: Full=Apolipoprotein A5;
DE   AltName: Full=Regeneration-associated protein 3;
DE   Flags: Precursor;
GN   Name=Apoa5; Synonyms=Rap3;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND INDUCTION.
RC   STRAIN=Wistar; TISSUE=Liver;
RX   PubMed=11577099; DOI=10.1074/jbc.m106888200;
RA   van Der Vliet H.N., Sammels M.G., Leegwater A.C.J., Levels J.H.M.,
RA   Reitsma P.H., Boers W., Chamuleau R.A.F.M.;
RT   "Apolipoprotein A-V. A novel apolipoprotein associated with an early phase
RT   of liver regeneration.";
RL   J. Biol. Chem. 276:44512-44520(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Liver;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-52, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Minor apolipoprotein mainly associated with HDL and to a
CC       lesser extent with VLDL (By similarity). May also be associated with
CC       chylomicrons (By similarity). Important determinant of plasma
CC       triglyceride (TG) levels by both being a potent stimulator of apo-CII
CC       lipoprotein lipase (LPL) TG hydrolysis and an inhibitor of the hepatic
CC       VLDL-TG production rate (without affecting the VLDL-apoB production
CC       rate) (By similarity). Activates poorly lecithin:cholesterol
CC       acyltransferase (LCAT) and does not enhance efflux of cholesterol from
CC       macrophages (By similarity). Binds heparin (By similarity).
CC       {ECO:0000250|UniProtKB:Q6Q788, ECO:0000250|UniProtKB:Q8C7G5}.
CC   -!- SUBUNIT: Interacts with GPIHBP1 (By similarity). Interacts with SORL1;
CC       this interaction leads to APOA5 internalization and sorting either to
CC       lysosomes and degradation, or to the trans-Golgi network (By
CC       similarity). {ECO:0000250|UniProtKB:Q6Q788}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000250|UniProtKB:Q6Q788}. Early
CC       endosome {ECO:0000250|UniProtKB:Q6Q788}. Late endosome
CC       {ECO:0000250|UniProtKB:Q6Q788}. Golgi apparatus, trans-Golgi network
CC       {ECO:0000250|UniProtKB:Q6Q788}. Note=In the presence of SORL1,
CC       internalized to early endosomes, sorted in a retrograde fashion to late
CC       endosomes, from which a portion is sent to lysosomes and degradation,
CC       another portion is sorted to the trans-Golgi network.
CC       {ECO:0000250|UniProtKB:Q6Q788}.
CC   -!- TISSUE SPECIFICITY: Liver. {ECO:0000269|PubMed:11577099}.
CC   -!- INDUCTION: Induced in early phase of liver regeneration. Expression is
CC       maximally increased 6 hours after partial hepatectomy, both at the
CC       liver RNA level and at the plasma protein level.
CC       {ECO:0000269|PubMed:11577099}.
CC   -!- PTM: Phosphorylated by FAM20C in the extracellular medium.
CC       {ECO:0000250|UniProtKB:Q6Q788}.
CC   -!- SIMILARITY: Belongs to the apolipoprotein A1/A4/E family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF202887; AAF25659.1; -; mRNA.
DR   EMBL; AF202888; AAF25660.1; -; mRNA.
DR   EMBL; BC089780; AAH89780.1; -; mRNA.
DR   RefSeq; NP_001264193.1; NM_001277264.1.
DR   RefSeq; NP_542143.1; NM_080576.2.
DR   AlphaFoldDB; Q9QUH3; -.
DR   SMR; Q9QUH3; -.
DR   IntAct; Q9QUH3; 1.
DR   STRING; 10116.ENSRNOP00000024918; -.
DR   iPTMnet; Q9QUH3; -.
DR   PhosphoSitePlus; Q9QUH3; -.
DR   PaxDb; 10116-ENSRNOP00000024918; -.
DR   GeneID; 140638; -.
DR   KEGG; rno:140638; -.
DR   UCSC; RGD:70903; rat.
DR   AGR; RGD:70903; -.
DR   CTD; 116519; -.
DR   RGD; 70903; Apoa5.
DR   eggNOG; ENOG502S33P; Eukaryota.
DR   HOGENOM; CLU_747959_0_0_1; -.
DR   InParanoid; Q9QUH3; -.
DR   OrthoDB; 4355748at2759; -.
DR   PhylomeDB; Q9QUH3; -.
DR   TreeFam; TF334458; -.
DR   Reactome; R-RNO-381426; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs).
DR   Reactome; R-RNO-8957275; Post-translational protein phosphorylation.
DR   Reactome; R-RNO-8963901; Chylomicron remodeling.
DR   PRO; PR:Q9QUH3; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0042627; C:chylomicron; ISO:RGD.
DR   GO; GO:0005769; C:early endosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005576; C:extracellular region; ISO:RGD.
DR   GO; GO:0005615; C:extracellular space; IDA:RGD.
DR   GO; GO:1903561; C:extracellular vesicle; IBA:GO_Central.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell.
DR   GO; GO:0034364; C:high-density lipoprotein particle; ISO:RGD.
DR   GO; GO:0005770; C:late endosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0034361; C:very-low-density lipoprotein particle; ISO:RGD.
DR   GO; GO:0120020; F:cholesterol transfer activity; IBA:GO_Central.
DR   GO; GO:0008047; F:enzyme activator activity; ISO:RGD.
DR   GO; GO:0019899; F:enzyme binding; ISO:RGD.
DR   GO; GO:0008201; F:heparin binding; ISO:RGD.
DR   GO; GO:0060229; F:lipase activator activity; ISO:RGD.
DR   GO; GO:0035473; F:lipase binding; ISO:RGD.
DR   GO; GO:0008289; F:lipid binding; ISO:RGD.
DR   GO; GO:0060230; F:lipoprotein lipase activator activity; ISO:RGD.
DR   GO; GO:0070325; F:lipoprotein particle receptor binding; ISO:RGD.
DR   GO; GO:0050750; F:low-density lipoprotein particle receptor binding; ISO:RGD.
DR   GO; GO:0031210; F:phosphatidylcholine binding; ISO:RGD.
DR   GO; GO:0060228; F:phosphatidylcholine-sterol O-acyltransferase activator activity; IBA:GO_Central.
DR   GO; GO:0005543; F:phospholipid binding; ISO:RGD.
DR   GO; GO:0055090; P:acylglycerol homeostasis; ISO:RGD.
DR   GO; GO:0031100; P:animal organ regeneration; IEP:RGD.
DR   GO; GO:0033344; P:cholesterol efflux; IBA:GO_Central.
DR   GO; GO:0042632; P:cholesterol homeostasis; ISO:RGD.
DR   GO; GO:0008203; P:cholesterol metabolic process; IBA:GO_Central.
DR   GO; GO:0006869; P:lipid transport; IMP:RGD.
DR   GO; GO:0042157; P:lipoprotein metabolic process; IEA:InterPro.
DR   GO; GO:0033700; P:phospholipid efflux; IBA:GO_Central.
DR   GO; GO:0045723; P:positive regulation of fatty acid biosynthetic process; ISO:RGD.
DR   GO; GO:0050996; P:positive regulation of lipid catabolic process; ISO:RGD.
DR   GO; GO:0010898; P:positive regulation of triglyceride catabolic process; ISO:RGD.
DR   GO; GO:0010902; P:positive regulation of very-low-density lipoprotein particle remodeling; ISO:RGD.
DR   GO; GO:0009725; P:response to hormone; IEP:RGD.
DR   GO; GO:0042246; P:tissue regeneration; ISO:RGD.
DR   GO; GO:0019433; P:triglyceride catabolic process; ISO:RGD.
DR   GO; GO:0070328; P:triglyceride homeostasis; ISO:RGD.
DR   GO; GO:0006641; P:triglyceride metabolic process; ISO:RGD.
DR   GO; GO:0034370; P:triglyceride-rich lipoprotein particle remodeling; ISO:RGD.
DR   Gene3D; 1.20.120.20; Apolipoprotein; 2.
DR   InterPro; IPR000074; ApoA_E.
DR   InterPro; IPR050163; Apolipoprotein_A1/A4/E.
DR   PANTHER; PTHR18976; APOLIPOPROTEIN; 1.
DR   PANTHER; PTHR18976:SF13; APOLIPOPROTEIN A-V; 1.
DR   Pfam; PF01442; Apolipoprotein; 2.
DR   SUPFAM; SSF58113; Apolipoprotein A-I; 1.
PE   1: Evidence at protein level;
KW   Chylomicron; Coiled coil; Endosome; Golgi apparatus; HDL; Lipid transport;
KW   Phosphoprotein; Reference proteome; Secreted; Signal; Transport; VLDL.
FT   SIGNAL          1..20
FT                   /evidence="ECO:0000255"
FT   CHAIN           21..367
FT                   /note="Apolipoprotein A-V"
FT                   /id="PRO_0000001983"
FT   REGION          305..332
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          231..255
FT                   /evidence="ECO:0000255"
FT   MOD_RES         52
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
SQ   SEQUENCE   367 AA;  41427 MW;  D5B1A4F4CB016478 CRC64;
     MAAVITWALA LLSVFATVQA RKSFWEYFGQ NSQGKGMMGQ QQKLAQESLK GSLEQDLYNM
     NNFLEKLGPL REPGKEPPRL AQDPEGIRKQ LQQELEEVST RLEPYMAAKH QQVGWNLEGL
     RQQLKPYTVE LMEQVGLSVQ DLQEQLRMVG KGTKAQLLGG VDEAMSLLQD MQSRVLHHTD
     RVKELFHPYA ERLVTGIGHH VQELHRSVAP HAVASPARLS RCVQTLSHKL TRKAKDLHTS
     IQRNLDQLRD ELSTFIRVST DGADNRDSLD PQALSDEVRQ RLQAFRHDTY LQIAAFTQAI
     DQETEEIQHQ LAPPPPSHSA FAPELGHSDS NKALSRLQSR LDDLWEDIAY GLHDQGHSQN
     NPEGHSG
//
